Here are five notes:
1. The shareholder sold 467,293 shares of the stock.
2. Each share sold at an average price of $22.60.
3. K2M, a global medical device company, presently has a consensus rating of “Buy” and a price target of $28.75.
4. K2M shares have a 50-day moving average of $24.27 and a 200-day moving average of $22.29.
5. The company’s market cap is approximately $958 million.
More on devices:
Stryker moves to dismisses lawsuit involving Accolade hip replacement system — 4 quick facts
Bone grafts market growing globally: 5 things to know
4 notes on new FDA-approved prosthesis for amputations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
